Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
87,311.14
75,725.07
68,383.23
59,532.83
52,757.18
60,435.23
61,823.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
87,311.14
75,725.07
68,383.23
59,532.83
52,757.18
60,435.23
61,823.76
Raw Material Cost
29,201.51
25,543.75
23,265.81
17,384.58
15,796.48
16,643.61
17,752.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
452.29
457.80
337.28
315.46
238.19
228.64
199.65
Selling and Distribution Expenses
41,805.36
36,737.76
32,646.31
30,992.85
28,073.31
33,439.25
33,502.02
Other Expenses
365.44
326.91
311.89
447.39
517.35
611.41
663.24
Total Expenditure (Excl Depreciation)
75,113.55
66,008.43
59,368.25
53,166.77
49,281.47
56,425.60
58,086.69
Operating Profit (PBDIT) excl Other Income
12197.6
9716.6
9015
6366.1
3475.7
4009.6
3737.1
Other Income
1,081.99
-250.66
-1,082.52
-100.88
343.05
139.28
157.67
Operating Profit (PBDIT)
20,834.27
17,021.43
14,080.72
11,665.73
8,254.82
8,093.17
7,628.58
Interest
452.29
457.80
337.28
315.46
238.19
228.64
199.65
Exceptional Items
-208.67
500.21
-322.47
-227.96
375.98
0.00
1,525.92
Gross Profit (PBDT)
58,109.63
50,181.32
45,117.42
42,148.25
36,960.70
43,791.62
44,071.11
Depreciation
7,554.69
7,555.45
6,148.27
5,400.55
4,436.06
3,944.25
3,733.85
Profit Before Tax
12,618.61
9,508.39
7,272.70
5,721.76
3,956.55
3,920.28
5,221.01
Tax
2,650.61
1,813.18
1,065.89
1,746.97
801.71
981.47
1,757.21
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
9,936.32
7,731.26
6,195.86
3,961.18
3,143.12
2,925.38
3,454.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
9,936.32
7,731.26
6,195.86
3,961.18
3,143.12
2,925.38
3,454.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
31.68
-36.05
10.95
13.61
11.71
13.44
9.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
9,968.00
7,695.21
6,206.81
3,974.79
3,154.84
2,938.81
3,463.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
89,539.84
79,622.56
65,449.92
54,894.64
55,985.27
52,510.46
59,185.59
Earnings per share (EPS)
225.42
175.39
140.26
87.76
68.22
62.62
69.56
Diluted Earnings per share
225.42
175.39
140.26
87.76
68.22
62.62
69.56
Operating Profit Margin (Excl OI)
13.97%
12.83%
13.18%
10.69%
6.59%
6.63%
6.04%
Gross Profit Margin
23.11%
22.53%
19.63%
18.68%
15.91%
13.01%
14.48%
PAT Margin
11.38%
10.21%
9.06%
6.65%
5.96%
4.84%
5.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 15.30% vs 10.74% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 29.54% vs 23.98% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 14.36% vs 13.91% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -1.20% vs 35.72% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Zeria Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
87,311.14
1,30,087.00
-42,775.86
-32.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
87,311.14
1,30,087.00
-42,775.86
-32.88%
Raw Material Cost
29,201.51
70,573.00
-41,371.49
-58.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
452.29
173.00
279.29
161.44%
Selling and Distribution Expenses
41,805.36
36,453.00
5,352.36
14.68%
Other Expenses
365.44
1,034.10
-668.66
-64.66%
Total Expenditure (Excl Depreciation)
75,113.55
1,17,540.00
-42,426.45
-36.10%
Operating Profit (PBDIT) excl Other Income
12,197.59
12,547.00
-349.41
-2.78%
Other Income
1,081.99
718.00
363.99
50.69%
Operating Profit (PBDIT)
20,834.27
17,868.00
2,966.27
16.60%
Interest
452.29
173.00
279.29
161.44%
Exceptional Items
-208.67
-319.00
110.33
34.59%
Gross Profit (PBDT)
58,109.63
59,514.00
-1,404.37
-2.36%
Depreciation
7,554.69
4,603.00
2,951.69
64.13%
Profit Before Tax
12,618.61
12,770.00
-151.39
-1.19%
Tax
2,650.61
3,684.00
-1,033.39
-28.05%
Provisions and contingencies
0
0
0.00
Profit After Tax
9,936.32
9,086.00
850.32
9.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
9,936.32
9,086.00
850.32
9.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
31.68
0.00
31.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
9,968.00
9,086.00
882.00
9.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
89,539.84
1,36,285.00
-46,745.16
-34.30%
Earnings per share (EPS)
225.42
158.16
67.26
42.53%
Diluted Earnings per share
225.42
158.16
67.26
42.53%
Operating Profit Margin (Excl OI)
13.97%
9.65%
0.00
4.32%
Gross Profit Margin
23.11%
13.35%
0.00
9.76%
PAT Margin
11.38%
6.98%
0.00
4.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 8,731.11 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 15.30% vs 10.74% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 996.80 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 29.54% vs 23.98% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,975.23 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 14.36% vs 13.91% in Mar 2024
Annual - Interest
Interest 45.23 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -1.20% vs 35.72% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.97%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
